Atamparib in Patients With Advanced Solid Tumors
Atamparib in Patients With Advanced Solid Tumors
Recruiting · NCT07374419 · Registry updated 2026-07-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Atamparib in Patients With Advanced Solid Tumors | Chemically-Induced Disorders, basal ganglia disorder, brain disorder, central nervous system disorder, nervous system disorder, neuroleptic malignant syndrome, poisoning, toxic encephalopathy | Recruiting | Phase 1 / Phase 2 | 2026-07-29 | NCT07374419 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nerviano Medical Sciences (Shanghai) Ltd. | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Unit 3.53, 3rd Floor, No. 5, Lane 720 Cailun Road, Pilot Free Trade Zone, Shanghai, P.R.China | Shanghai | China | 1 |